Journal of International Medical Research,
Journal Year:
2018,
Volume and Issue:
47(1), P. 481 - 493
Published: Dec. 16, 2018
Objective
Long
noncoding
RNAs
(lncRNAs)
are
important
mediators
in
tumor
progression.
intergenic
RNA-p21
(lincRNA-p21)
participates
multiple
biological
processes.
This
study
explored
the
role
of
lincRNA-p21
human
non-small
cell
lung
cancer
(NSCLC)
progression
and
potential
regulatory
mechanisms.
Methods
LincRNA-p21
expression
NSCLC
tissues
lines
(A549,
H1299,
H1650,
NCI-H2087)
was
determined
by
quantitative
real-time
PCR.
overexpressing
sh-lincRNA-p21
lentiviral
were
respectively
transfected
into
H1299
A549
cells.
Flow
cytometry
used
to
measure
apoptosis.
Microarray
analysis
RNA
pull-down
assay
predict
target
genes
lincRNA-p21.
Finally,
PUMA
siRNA
cells,
extent
apoptosis
measured.
The
protein
levels
relative
confirmed
western
blot
analysis.
Results
significantly
upregulated
upregulation
considerably
inhibited
while
downregulation
showed
opposite
effect.
a
direct
gene
negatively
correlated
with
specimens.
anti-apoptotic
effect
can
be
effectively
attenuated
PUMA.
Conclusion
is
aberrantly
inhibits
decreasing
expression.
Cell Cycle,
Journal Year:
2017,
Volume and Issue:
16(22), P. 2212 - 2219
Published: Sept. 7, 2017
Recently,
long
non-coding
RNAs
(lncRNAs)
have
emerged
as
new
gene
regulators
and
prognostic
markers
in
several
types
of
cancer,
including
renal
cell
carcinoma
(RCC).
In
this
study,
we
identified
an
upregulated
lncRNA,
DLX6-AS1,
RCC
tumor
tissues
compared
with
normal
kidney
tissues.
Our
data
suggested
that
DLX6-AS1
promoted
growth
tumorigenesis
via
targeting
miR-26a.
addition,
observed
PTEN
overexpression
restored
the
cancer
also
rescued
tumorigenesis.
summary,
conclude
promotes
development
regulation
miR-26a/PTEN
axis.
Aging,
Journal Year:
2019,
Volume and Issue:
11(23), P. 11416 - 11439
Published: Dec. 3, 2019
Ovarian
cancer
is
one
of
the
most
common
and
lethal
types
in
women.
The
molecular
mechanism
ovarian
progression
still
unclear.Here,
we
first
reported
that
expression
levels
three
genes,
GJB2,
S100A2
SPOCK2,
were
significantly
higher
advanced
stage
than
early
cancer,
upregulation
them
indicated
poor
prognosis
patients
with
cancer.
Subsequently,
8,
6
20
miRNAs
predicted
to
target
respectively.
Among
these
miRNA-mRNA
pairs,
hsa-miR-363-3p-SPOCK2
axis
was
potential
suppressing
Mechanistically,
found
involved
regulation
actin
cytoskeleton.
Moreover,
pseudogenes
8
lncRNAs
identified
potentially
inhibit
cancer.Collectively,
elucidate
a
regulatory
role
pseudogene/lncRNA-hsa-miR-363-3p-SPOCK2
pathway
which
may
provide
effective
therapeutic
approaches
promising
prognostic
biomarkers
for
cancer.Differentially
expressed
genes
(DEGs)
screened
using
GSE12470,
after
DEGs
validated
GEPIA.
Kaplan-Meier
analysis
employed
assess
values.
Potential
by
seven
prediction
databases,
upstream
hsa-miR-363-3p
forecasted
through
miRNet
or
starBase.
UALCAN
starBase
used
obtain
co-expressed
SPOCK.
Enrichment
performed
Enrichr.
Molecular Therapy — Nucleic Acids,
Journal Year:
2017,
Volume and Issue:
10, P. 170 - 186
Published: Nov. 26, 2017
Glioma
is
recognized
as
a
highly
angiogenic
malignant
brain
tumor.
Vasculogenic
mimicry
(VM)
greatly
restricts
the
therapeutic
effect
of
anti-angiogenic
tumor
therapy
for
glioma
patients.
However,
molecular
mechanisms
VM
formation
in
remain
unclear.
Here,
we
demonstrated
that
LINC00339
was
upregulated
tissue
well
cell
lines.
The
expression
tissues
positively
correlated
with
formation.
Knockdown
inhibited
proliferation,
migration,
invasion,
and
tube
formation,
meanwhile
downregulating
VM-related
MMP-2
MMP-14.
Furthermore,
knockdown
significantly
increased
miR-539-5p.
Both
bioinformatics
luciferase
reporter
assay
revealed
regulated
above
effects
via
binding
to
Besides,
overexpression
miR-539-5p
resulted
decreased
TWIST1,
transcription
factor
known
play
an
oncogenic
role
identified
direct
target
TWIST1
promoter
activities
vivo
study
showed
nude
mice
carrying
tumors
exhibited
smallest
volume
through
inhibiting
In
conclusion,
may
be
used
novel
glioma.
PLoS Genetics,
Journal Year:
2019,
Volume and Issue:
15(8), P. e1008325 - e1008325
Published: Aug. 20, 2019
The
role
of
long
non-coding
RNA
(lncRNA)
in
the
progression
Nasopharyngeal
carcinoma
(NPC)
has
not
been
fully
elucidated.
study
was
designed
to
explore
functional
NKILA,
a
newly
identified
lncRNA,
NPC.
We
performed
lncRNA
expression
profile
microarray
using
four
NPC
and
paired
para-cancerous
tissues.
NKILA
as
potential
by
this
profile.
used
107
paraffin-embedded
tissues
with
different
TNM
stages
detect
analyzed
survival
data
Log-rank
test
Cox
regression.
its
underlying
mechanisms
were
evaluated
series
experiments
vitro
vivo
silencing
or
expressing
NKILA.
Compared
control
tissues,
be
decreased
Low
correlated
unfavorable
clinicopathological
features
predicted
poor
outcome
patients.
After
adjusting
for
confounders,
low
confirmed
an
independent
prognostic
factor
outcomes.
Furthermore,
we
found
that
overexpression
high-metastatic-potential
cells
repressed
motile
behavior
impaired
metastatic
capacity
vivo.
In
contrast,
RNAi-mediated
depletion
increased
invasive
motility
lower
potential.
Further
demonstrated
regulated
metastasis
through
NF-κB
pathway.
Taken
together,
plays
vital
roles
pathogenesis
unique
histological
characteristics
indicate
local
inflammation
carcinogenesis
nasopharyngeal
carcinoma.
Journal of Cellular Physiology,
Journal Year:
2018,
Volume and Issue:
234(6), P. 9408 - 9416
Published: Nov. 14, 2018
Long
noncoding
RNA
(lncRNA)
differentiation
antagonizing
nonprotein
coding
(DANCR)
has
been
identified
as
an
oncogene
in
several
cancers.
However,
the
biological
function
and
role
of
DANCR
hepatocellular
carcinoma
(HCC)
remain
unclear.
Our
current
study
aimed
to
investigate
detailed
mechanism
HCC.
We
found
that
was
significantly
upregulated
HCC
cell
lines
comparison
LO2
cells.
Then,
we
observed
knockdown
could
greatly
inhibit
Huh7
HepG2
proliferation.
In
addition,
apoptosis
increased
by
silence
meanwhile,
cycle
progression
blocked
G1
phase.
Apart
from
these,
downregulation
repressed
migration
invasion
ability
obviously.
As
predicted
bioinformatics
analysis,
microRNA-216a-5p
(miR-216a-5p)
serve
a
direct
target
DANCR.
MiR-216a-5p
reported
be
involved
many
Here,
correlation
between
miR-216a-5p
confirmed
using
dual-luciferase
reporter
assay
radioimmunoprecipitation
assay.
Subsequently,
Kruppel-like
factor
12
(KLF12)
exerts
important
different
tumor
types.
KLF12
can
downstream
miR-216a-5p.
Finally,
vivo
experiments
were
used
data
proved
also
strongly
suppressed
growth
via
targeting
KLF12.
conclusion,
our
indicated
might
provide
new
perspective
for
treatment.
OncoTargets and Therapy,
Journal Year:
2017,
Volume and Issue:
Volume 10, P. 4753 - 4763
Published: Sept. 1, 2017
Abstract:
Non-small
cell
lung
cancer
(NSCLC)
is
one
of
the
most
common
malignancies
worldwide,
and
it
occurs
at
a
higher
frequency
in
males.
HOXD-AS1,
an
important
cancer-associated
long
noncoding
RNA
(lncRNA),
contributes
to
development
progression
several
cancers.
However,
exact
roles
HOXD-AS1
NSCLC
are
still
unknown.
Here,
we
investigated
underlying
mechanisms
human
tissues.
We
found
that
lncRNA
was
specifically
upregulated
(
P
<0.001)
tissues
promoted
growth
by
targeting
miR-147a.
Moreover,
expression
positively
correlated
with
clinical
pathologic
characteristics
(tumor
size,
=0.006;
tumor
stage,
=0.044;
recurrence,
=0.031)
survival
rate
=0.003).
knockdown
reduced
proliferation
apoptosis
cells.
The
dual-luciferase
reporter
assay
showed
could
negatively
regulate
miR-147a
inhibition
abrogated
effect
on
Furthermore,
regulated
pRB
(a
suppressor
protein)
Taken
together,
our
data
indicated
might
be
oncogenic
promotes
therapeutic
target
NSCLC.
Keywords:
non-small
cancer,
proliferation,